Huan Gong

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Vascular Endothelial Growth Factor

Toll Like Receptor

Inflammatory Response

Top Venues

Oxidative medicine and cellular longevity

Beijing Hospital

Chinese Academy of Medical Sciences and Peking Union Medical College (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Beijing Hospital Jul 01 2015

China

Associate Professor :: Beijing Institute of Geriatrics

Beijing Hospital Aug 01 2007 - Jun 30 2015

China

Assisstant Researcher :: Beijing Institute of Geriatrics

Yale University School of Medicine Dec 05 2010 - Dec 31 2012

United States

Postdoctoral

Education History

Chinese Academy of Medical Sciences and Peking Union Medical College Jul 20 2003 - Jul 31 2007

China

PHD :: Biochemistry and Molecular Biology

Beijing Institute of Geriatrics Sep 01 2000 - Jul 31 2003

China

MSC :: Cell biology

Shandong University Sep 01 1995 - Jul 31 1999

China

BSC :: Biochemistry and Molecular biology

Publications

Huan Gong, Ming Zhang, Yiwen Han, Ying Zhang, Jing Pang, Yanyang Zhao, Beidong Chen, Wei Wu, Ruomei Qi, Tiemei Zhang
Differential microRNAs expression profiles in liver from three different lifestyle modification mice models. BMC genomics 22 (1) (2021)
Yun Xue, Huilian Chen, Shenghao Zhang, Li Bao, Beidong Chen, Huan Gong, Yanyang Zhao, Ruomei Qi
Resveratrol Confers Vascular Protection by Suppressing TLR4/Syk/NLRP3 Signaling in Oxidized Low-Density Lipoprotein-Activated Platelets. Oxidative medicine and cellular longevity 2021 (2021)
Ming Zhang, Yun Xue, Huilian Chen, Lingbing Meng, Beidong Chen, Huan Gong, Yanyang Zhao, Ruomei Qi
Resveratrol Inhibits MMP3 and MMP9 Expression and Secretion by Suppressing TLR4/NF-κB/STAT3 Activation in Ox-LDL-Treated HUVECs. Oxidative medicine and cellular longevity 2019 (2019)
Kun Chen, Wenjia Sun, Yun Jiang, Beidong Chen, Yanyang Zhao, Jie Sun, Huan Gong, Ruomei Qi
Ginkgolide B Suppresses TLR4-Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose-Treated HUVECs. Oxidative medicine and cellular longevity 2017 (2017)